1,5-dihydroxyisoquinoline has been researched along with Ventricular Dysfunction, Left in 1 studies
1,5-dihydroxyisoquinoline: structure in first source
isoquinoline-1,5-diol : An isoquinolinol that is isoquinoline in which the hydrogens at positions 1 and 5 are replaced by hydroxy groups.
Ventricular Dysfunction, Left: A condition in which the LEFT VENTRICLE of the heart was functionally impaired. This condition usually leads to HEART FAILURE; MYOCARDIAL INFARCTION; and other cardiovascular complications. Diagnosis is made by measuring the diminished ejection fraction and a depressed level of motility of the left ventricular wall.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Docherty, JC | 1 |
| Kuzio, B | 1 |
| Silvester, JA | 1 |
| Bowes, J | 1 |
| Thiemermann, C | 1 |
1 other study available for 1,5-dihydroxyisoquinoline and Ventricular Dysfunction, Left
| Article | Year |
|---|---|
An inhibitor of poly (ADP-ribose) synthetase activity reduces contractile dysfunction and preserves high energy phosphate levels during reperfusion of the ischaemic rat heart.
Topics: Adenosine Triphosphate; Animals; Blood Pressure; Cardiotonic Agents; Diastole; Enzyme Inhibitors; He | 1999 |